shapiro

Business News

Hemostemix to Combine ACP-01 with Dr. James Shapiro’s Islet Cells to Treat Type 1 Diabetes – Press Release

[ad_1] Calgary, Alberta–(Newsfile Corp. – January 11, 2022) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (“Hemostemix” or the…

Read More »
Back to top button